Solution structure of mouse cripto CFC domain and its inactive variant Trp107Ala

Journal of Medicinal Chemistry

Volumn 49, Issue 24, 2006, Pages 7054-7062

  Calvanese, Luisa ^a   Saporito, Angela ^b   Marasco, Daniela ^b   D'Auria, Gabriella ^b   Minchiotti, Gabriella ^c   Pedone, Carlo ^b   Paolillo, Livio ^b   Falcigno, Lucia ^b   Ruvo, Menotti ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; ALANINE; EPIDERMAL GROWTH FACTOR; HISTIDINE; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN CRIPTO; TRYPTOPHAN;

ARTICLE; CELL MEMBRANE; DISULFIDE BOND; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PH; POINT MUTATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; EPIDERMAL GROWTH FACTOR; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE GLYCOPROTEINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS;

EID: 33845352894     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060772r     Document Type: Article

References (58)

1. Adkins, H. B.; Bianco, C.; Schiffer, S. G.; Rayhorn, P.; Zafari, M.; et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 2003, 112, 575-587.
2. Xing, P. X.; Hu, X. F.; Pietersz, G. A.; Hosick, H. L.; McKenzie, I. F. Cripto: a novel target for antibody-based cancer immunotherapy. Cancer Res. 2004, 64, 4018-4023.
3. Bianco, C.; Strizzi, L.; Normanno, N.; Khan, N.; Salomon, D. S. Cripto-1: an oncofetal gene with many faces. Curr. Top. Dev. Biol. 2005, 67, 85-133.
4. Hu, X. F.; Xing, P. X. Cripto as a target for cancer immunotherapy. Expert Opin. Ther. Targets 2005, 9, 383-394.
5. Niemeyer, C. C.; Persico, M. G.; Adamson, E. D. Cripto: roles in mammary cell growth, survival, differentiation and transformation. Cell Death Differ. 1998, 5, 440-449.
6. Xu, C.; Liguori, G.; Persico, M. G.; Adamson, E. D. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development 1999, 126, 483-494.
7. Salomon, D. S.; Bianco, C.; Ebert, A. D.; Khan, N. I.; De Santis, M.; et al. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr.-Relat. Cancer 2000, 7, 199-226.
8. Sun, Y.; Strizzi, L.; Raafat, A.; Hirota, M.; Bianco, C.; et al. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am. J. Pathol. 2005, 167, 585-597.
9. Wechselberger, C.; Strizzi, L.; Kenney, N.; Hirota, M.; Sun, Y.; et al. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 2005, 24, 4094-4105.
10. Minchiotti, G.; Parisi, S.; Liguori, G. L.; D'Andrea, D.; Persico, M. G. Role of the EGF-CFC gene cripto in cell differentiation and embryo development. Gene 2002, 287, 33-37.
11. Sonntag, K. C.; Simantov, R.; Bjorklund, L.; Cooper, O.; Pruszak, J.; et al. Context-dependent neuronal differentiation and germ layer induction of Smad4-/- and Cripto-/- embryonic stem cells. Mol. Cell Neurosci. 2005, 28, 417-429.
12. Kenney, N. J.; Adkins, H. B.; Sanicola, M. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 2004, 9, 133-144.
13. Adamson, E. D.; Minchiotti, G.; Salomon, D. S. Cripto: a tumor growth factor and more. J. Cell. Physiol. 2002, 190, 267-278.
14. Parisi, S.; D'Andrea, D.; Lago, C. T.; Adamson, E. D.; Persico, M. G.; et al. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J. Cell Biol. 2003, 163, 303-314.
15. Gerecht-Nir, S.; Dazard, J. E.; Golan-Mashiach, M.; Osenberg, S.; Botvinnik, A.; et al. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Dev. Dyn. 2005, 232, 487-497.
16. Li, Y.; Powell, S.; Brunette, E.; Lebkowski, J.; Mandalam, R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 2005, 91, 688-698.
17. Liu, H.; Harris, T. M.; Kim, H. H.; Childs, G. Cardiac myocyte differentiation: the Nkx2.5 and Cripto target genes in P19 clone 6 cells. Funct. Integr. Genomics 2005, 5, 218-239.
18. Minchiotti, G. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology. Oncogene 2005, 24, 5668-5675.
19. Bianco, C.; Strizzi, L.; Ebert, A.; Chang, C.; Rehman, A.; et al. Role of human cripto-1 in tumor angiogenesis. J. Natl. Cancer Inst. 2005, 97, 132-141.
20. Sakuma, R.; Ohnishi Yi, Y.; Meno, C.; Fujii, H.; Juan, H.; et al. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 2002, 7, 401-412.
21. Yan, Y. T.; Liu, J. J.; Luo, Y.; E, C.; Haltiwanger, R. S.; et al. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol. Cell Biol. 2002, 22, 4439-4449.
22. Yeo, C.; Whitman, M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol. Cell 2001, 7, 949-957.
23. Schier, A. F. Nodal signaling in vertebrate development. Annu. Rev. Cell Dev. Biol. 2003, 19, 589-621.
24. Chen, C.; Ware, S. M.; Sato, A.; Houston-Hawkins, D. E.; Habas, R.; et al. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 2006, 133, 319-329.
25. Cheng, S. K.; Olale, F.; Bennett, J. T.; Brivanlou, A. H.; Schier, A. F. EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev. 2003, 17, 31-36.
26. Gray, P. C.; Harrison, C. A.; Vale, W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 5193-5198.
27. Cheng, S. K.; Olale, F.; Brivanlou, A. H.; Schier, A. F. Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS Biol. 2004, 2, E30.
28. Bianco, C.; Strizzi, L.; Rehman, A.; Normanno, N.; Wechselberger, C.; et al. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res. 2003, 63, 1192-1197.
29. Lohmeyer, M.; Harrison, P. M.; Kannan, S.; DeSantis, M.; O'Reilly, N. J.; et al. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. Biochemistry 1997, 36, 3837-3845.
30. Foley, S. F.; van Vlijmen, H. W.; Boynton, R. E.; Adkins, H. B.; Cheung, A. E.; et al. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis. Eur. J. Biochem. 2003, 270, 3610-3618.
31. Marasco, D.; Saporito, A.; Ponticelli, S.; Chambery, A.; De Falco, S.; et al. Chemical synthesis of mouse cripto CFC variants. Proteins 2006, 64, 779-788.
32. Risbridger, G. P.; Schmitt, J. F.; Robertson, D. M. Activins and inhibins in endocrine and other tumors. Endocr. Rev. 2001, 22, 836-858.
33. Shen, M. M. Decrypting the role of Cripto in tumorigenesis. J. Clin. Invest. 2003, 112, 500-502.
34. Bianco, C.; Normanno, N.; Salomon, D. S.; Ciardiello, F. Role of the cripto (EGF-CFC) family in embryogenesis and cancer. Growth Factors 2004, 22, 133-139.
35. Hu, X. F.; Xing, P. X. Cripto monoclonal antibodies. Drug News Perspect. 2005, 18, 293-303.
36. Shen, M. M.; Schier, A. F. The EGF-CFC gene family in vertebrate development. Trends Genet. 2000, 16, 303-309.
37. Persico, M. G.; Liguori, G. L.; Parisi, S.; D'Andrea, D.; Salomon, D. S.; et al. Cripto in tumors and embryo development. Biochim. Biophys. Acta 2001, 1552, 87-93.
38. Wishart, D. S.; Sykes, B. D.; Richards, F. M. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 1991, 222, 311-333.
39. Guntert, P.; Mumenthaler, C.; Wuthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997, 273, 283-298.
40. Harrison, P. M.; Sternberg, M. J. E. The disulphide beta-cross: from cystine geometry and clustering to classification of small disulphide-rich protein folds. J. Mol. Biol. 1996, 264, 603-623.
41. Minchiotti, G.; Parisi, S.; Liguori, G.; Signore, M.; Lania, G. et al. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development. Mech. Dev. 2000, 90, 133-142.
42. Shi, S.; Stanley, P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 5234-5239.
43. Schiffer, S. G.; Foley, S.; Kaffashan, A.; Hronowski, X.; Zichittella, A. E.; et al. Fucosylation of Cripto is required for its ability to facilitate nodal signaling. J. Biol. Chem. 2001, 276, 37769-37778.
44. Bax, A.; Davis, D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Res. 1985, 65, 355-360.
45. Bax, A. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Res. 1985, 63, 207-213.
46. Piantini, U.; Sorensen, O. W.; Ernst, R. R. Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 1982, 104, 6800-6801.
47. States, D. J.; Haberhorn, R. A.; Ruben, D. J. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Res. 1982, 48, 286-292.
48. Piotto, M.; Saudek, V.; Skelnar, V. J. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 1992, 2, 661-665.
49. Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6, 277-293.
50. Johnson, B. A.; Blevins, R. A. NMRView: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 1994, 4, 603-614.
51. Wuthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
52. Guntert, P.; Braun, W.; Wuthrich, K. Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS, and GLOMSA. J. Mol. Biol. 1991, 217, 517-530.
53. Karplus, M. Vicinal proton coupling in nuclear magnetic resonance. J. Am. Chem. Soc. 1963, 85, 2870-2871.
54. Guntert, P.; Wuthrich, K. Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints. J. Biomol. NMR 1991, 1, 447-456.
55. Case, D. A.; Pearlman, D. A.; Caldwell, J. W.; Cheatham, I. T. E.; Ross, W. S.; et al. AMBER 6; University of California: San Francisco, CA, 1999.
56. Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, I. T. E.; et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to stimulate the structural and energetic properties of molecules. Proteins 1996, 26, 304-313.
57. Weiner, S. J.; Kollmann, P. A.; Nguyen, D. T.; Case, D. A. An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986, 7, 230-238.
58. Koradi, R.; Billeter, M.; Wuthrich, K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics Modell. 1996, 14, 51-55.